Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...

Adicet Bio (ACET) announced the FDA has granted fast track designation to ADI-001 for the potential treatment of adult patients with refractory ...

From gambling mercenaries to vicious criminals and even space felines, Citizen Sleeper 2 has some wild and memorable ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it ...